AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study 
Trump Signals Push for Lower Health Insurance Prices as ACA Premium Concerns Grow 
7-Eleven CEO Joe DePinto to Retire After Two Decades at the Helm 
California Regulator Probes Waymo Robotaxi Stalls During San Francisco Power Outage 
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program 
Bridgewater Associates Plans Major Employee Ownership Expansion in Milestone Year 
Niigata Set to Approve Restart of Japan’s Largest Nuclear Power Plant in Major Energy Shift 
Mexico Antitrust Review of Viva Aerobus–Volaris Deal Signals Growth for Airline Sector 
Warner Bros Discovery Weighs Amended Paramount Skydance Bid as Netflix Takeover Battle Intensifies 
Uber and Baidu Partner to Test Robotaxis in the UK, Marking a New Milestone for Autonomous Ride-Hailing 
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement 
ByteDance Plans Massive AI Investment in 2026 to Close Gap With U.S. Tech Giants 
Moore Threads Unveils New GPUs, Fuels Optimism Around China’s AI Chip Ambitions 
Saks Global Weighs Chapter 11 Bankruptcy Amid Debt Pressures and Luxury Retail Slowdown 
Google and Apple Warn U.S. Visa Holders to Avoid International Travel Amid Lengthy Embassy Delays 
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss 
FedEx Beats Q2 Earnings Expectations, Raises Full-Year Outlook Despite Stock Dip 
ALBUQUERQUE, N.M., April 26, 2016 -- TriCore Reference Laboratories' Chief Information Officer, Bill Baker, will address the audience at the Executive War College meeting on Tuesday, April 26, 2016.
Mr. Baker will explain how TriCore's early successes at advancing clinical care and improving patient outcomes will enrich clinical intelligence. TriCore is reshaping the way medicine is delivered through laboratory-driven population health management. Selecting the right test at the right time and converting the resulting data to actionable information, TriCore is helping to reduce the total cost of care and improve patient outcomes.
TriCore generates more than 70% of New Mexico's clinical test data. Combining years of longitudinal and chronological data with analytics powered by Rhodes technology, TriCore connects data from different providers and identifies geographic patterns.
"It is an exciting area for healthcare from clinical, technology and economic perspectives. Using advanced laboratory data analytics we can track patient care, outcomes, and the cost of care. This information adds value for physicians, patients, and payers by helping close gaps, improve outcomes, as well as reduce the cost of care," said Bill Baker, CIO of TriCore Reference Laboratories.
"Technology and integration of clinical lab data with predictive and actionable values create a unique business model. This new model focuses on our value proposition by bringing real data, performing population risk stratification, reducing the effect of latency and developing high risk targeted interventions" says Khosrow Shotorbani, CEO of TriCore Reference Laboratories. "Together with Rhodes, we are advancing analytics to drive improvements in patient and population health through targeted intervention to positively affect patient lives".
About TriCore
Founded in 1998 and headquartered in Albuquerque, New Mexico, TriCore Reference Laboratories is an independent, clinical reference laboratory that provides full-service, state of the art laboratory tests to health care professionals and their patients. TriCore offers more than 1,700 laboratory tests ranging from routine to highly specialized. TriCore participates in scientific research through collaboration with the University of New Mexico and numerous national and international biotech firms. TriCore is a CAP ISO 15189SM certified medical laboratory.
CONTACT: Media Contact:
Carol P Biondi
505-379-5616
[email protected]
